2 Growth Stocks Ready to Profit From Cannabis 2.0

The combination of Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) looks like a winning bet.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In October, the cannabis game changed forever, even if many pot investors weren’t paying attention. That month, Canada legalized an entire host of new marijuana categories, the most exciting of which included new edibles and beverages.

These form factors could eventually double or triple the size of the Canadian cannabis market. Analysts are calling this emerging opportunity “Cannabis 2.0.”

The opportunity is still in its early stages, however. If you’re paying attention, you could capitalize at bargain prices. If growth tracks as expected, some stock prices could go exponential.

Only one thing matters

If you want to capitalize on new consumables categories like beverages and edibles, it helps to look at what’s worked in other markets. The biggest thing a company can do to achieve massive success in consumer markets is to create a renowned brand.

There’s a reason why Coca-Cola Co and PepsiCo, Inc. are worth a combined $500 billion. McDonald’s Corp is worth more than $150 billion, while Kraft Heinz Co is worth $40 billion. Above all else, consumers buy what they know and trust.

The same behaviour will be applied to cannabis consumables. Would you rather buy a cannabis product from a brand you already love or from a company you’ve never heard of? Trust will play a major role in purchasing decisions, especially when it comes to new cannabis users.

This stock can win

Few cannabis companies are willing to admit that they need help from existing brands. Only one company has accepted this weakness, opting instead to partner with globally recognized brands with high levels of consumer recognition. That company is Hexo Corp (TSX:HEXO)(NYSE:HEXO).

Rather than creating its own pot brands from scratch, Hexo is leveraging brands that already have decades of consumer trust and billions of dollars in ad spending.

Here’s a perfect example. In October of 2019, THC-infused beverages were made legal in Canada. Within months, Hexo was able to get its first pot-based drinks to market.

These drinks will be marketed under one of Canada’s most trusted drink brands. How was it able to achieve this?

In 2018, Hexo created a joint venture with Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP), which has decades of experience and brand recognition.

Over the next 12 months, the companies combined their manufacturing capabilities to design and co-create marijuana-based drinks. When legalization occurred, the joint venture was able to beat all others to market.

Ask yourself one question: Will Canadian’s be more likely to buy a Molson Coors cannabis drink, or a cannabis drink from an unknown competitor?

The answer should be clear. When it comes to competing in this rapidly emerging category, the Hexo-Molson tie-up is lightyears ahead of the competition.

Globally, alcohol sales reached $1.4 trillion in 2019. How big could cannabis drink sales get? Virtually no one is paying attention to this opportunity.

Hexo is expected to generate just $80 million in sales this year. Molson, meanwhile, is expected to earn roughly $13 billion in revenue. The cannabis opportunity could have game-changing results for both companies.

If cannabis beverage demand growth becomes even a small fraction of alcohol demand, this category could add billions in sales for both Hexo and Molson.

That’s an opportunity the market isn’t pricing in. By getting in before sales traction hits, however, you can execute on this year’s best pot trade.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »